← Back to all trials
Active Not Recruiting
NCT05519553
Peer Support Impact on Therapeutic Adherence in Patients With Multiple Sclerosis
Conditions: Multiple Sclerosis, Relapsing-remitting
Sex: All
Ages: 18 Years – 95 Years
Healthy volunteers: No
Phase: NA
Enrollment: 60
Sponsor: Nantes University Hospital
Location: CHU de Nantes Nantes
Summary
A mixed methods randomized controlled trial pilot study to assess peer support impact on relapsing-remitting multiple sclerosis patients' therapeutic adherence.
Eligibility Criteria
Inclusion Criteria:
* Adult patients
* With relapsing-remitting MS according to 2017 revised Mc Donald criteria
* Attending medical consultation at Nantes University Hospital Neurology Department
* For whom background drug therapy is needed (oral or injectable)
* Who gave consent to participate in trial
Exclusion Criteria:
* Primary-progressive or secondary-progressive MS patients
* Patients under protection of vulnerable adults measure or convicted
* Patients not fluent in French
* Patients with severe cognitive impairment, who may find difficult filling out questionnaires properly
* Patients with a risk of follow-up interruption (move, nomadism…)
Source: ClinicalTrials.gov (NCT05519553). StuddyBuddy aggregates publicly available trial information.
